Clinical trial • Phase I • Oncology
BMS-986506 for Advanced clear cell renal cell carcinoma | Metastatic clear cell renal cell carcinoma
Phase I trial of BMS-986506 for Advanced clear cell renal cell carcinoma | Metastatic clear cell renal cell carcinoma. 77 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Advanced clear cell renal cell carcinoma | Metastatic clear cell renal cell carcinoma
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 13-11-2025
- First CTIS Authorization Date
- 09-02-2026
Trial design
Phase I trial in France, Spain.
- Target Sample Size
- 77
Recruitment
- Planned Sample Size
- 77
- Recruitment Window Months
- 30
Geography
- Total Number Of Sites
- 3
- Total Number Of Participants
- 48
France
- Earliest CTIS Part Ii Submission Date
- 06-02-2026
- Latest Decision Or Authorization Date
- 09-02-2026
- Processing Time Days
- 3
- Number Of Sites
- 1
- Number Of Participants
- 16
Sites
- Site Name
- Institut Gustave Roussy
- Department Name
- Innovation Thérapeutique et Essais Précoces
- Principal Investigator Name
- Christophe MASSARD
- Principal Investigator Email
- christophe.massard@gustaveroussy.fr
- Contact Person Name
- Christophe MASSARD
- Contact Person Email
- christophe.massard@gustaveroussy.fr
Spain
- Earliest CTIS Part Ii Submission Date
- 09-02-2026
- Latest Decision Or Authorization Date
- 16-02-2026
- Processing Time Days
- 7
- Number Of Sites
- 2
- Number Of Participants
- 32
Sites
- Site Name
- Hospital Universitario Reina Sofia
- Department Name
- Oncologia
- Principal Investigator Name
- Maria Jose Mendez Vidal
- Principal Investigator Email
- mj.mendez.sspa@juntadeandalucia.es
- Contact Person Name
- Maria Jose Mendez Vidal
- Contact Person Email
- mj.mendez.sspa@juntadeandalucia.es
- Site Name
- Hospital Universitari Vall D Hebron
- Department Name
- Oncologia-VHIO
- Principal Investigator Name
- Cristina Suarez Rodriguez
- Principal Investigator Email
- csuarez@vhio.net
- Contact Person Name
- Cristina Suarez Rodriguez
- Contact Person Email
- csuarez@vhio.net
Sponsor
Primary sponsor
- Full Name
- Bristol-Myers Squibb Services Unlimited Company
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Ireland
Investigational products
- Investigational Product Name
- BMS-986506
- First In Human
- Yes
Related trials
Other published trials that may interest you.
- GDC-9545 for Locally advanced or metastatic estrogen receptor-positive breast cancer
- Abemaciclib for Stage IV lung cancer | Breast cancer
- BGB-43395 for Advanced or metastatic solid tumors | Hormone receptor positive HER2 negative breast cancer
- AZD9833 for Estrogen receptor-positive HER2-negative advanced breast cancer
- Pembrolizumab for Classical Hodgkin lymphoma | Melanoma | Solid tumours (MSI-H/dMMR) | Solid tumours (TMB-H)